Page last updated: 2024-11-07

16-dehydroprogesterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID101964
CHEBI ID18204
SCHEMBL ID4661581
MeSH IDM0090778

Synonyms (41)

Synonym
pregna-4,16-diene-3,20-dione
delta(4,16)-pregnadiene-3,20-dione
CHEBI:18204
3,20-dioxopregna-4,16-diene
pregna-4,20-dione
nsc-9785
nsc-11037
nsc9785
nsc11037
.delta.16-progesterone
3,16-diene
nsc 11037
.delta.4,20-dione
1096-38-4
C03207
16-dehydroprogesterone
16,17-didehydroprogesterone
16-dehydroprogesterone, 97%
LMST02030163
(8r,9s,10r,13s,14s)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-one
delta4,16-pregnadiene-3,20-dione
ju0yq9dz2o ,
einecs 214-142-8
nsc 9785
unii-ju0yq9dz2o
S6140
4,16-pregnadiene-3,20-dione
AKOS022172049
SCHEMBL4661581
.delta.4,16-pregnadiene-3,20-dione
delta.16-progesterone
d4,16-pregnadiene-3,20-dione
d16-progesterone
DS-6807
DTXSID10862535
Q27102899
CS-0099261
HY-128378
16-?dehydroprogesterone
16-ehydroprogesterone
PD124055
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.
3-oxo-Delta(4) steroidA 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (50.00)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (12.50%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]